MétaCan
Menu
Back to cohort
Record W2340096214

Hyperacute rejection mimicry for cancer gene therapy

2004· article· en· W2340096214 on OpenAlexaff
James Larkin

Bibliographic record

VenueCancer Research · 2004
Typearticle
Languageen
FieldMedicine
TopicXenotransplantation and immune response
Canadian institutionsInstitute of Cancer Research
Fundersnot available
KeywordsXenotransplantationAntibodyComplement systemEpitopeBiologyImmunologyGenetically modified mouseMolecular biologyTransplantationCancer researchTransgeneMedicineGeneBiochemistryInternal medicine
DOInot available

Abstract

fetched live from OpenAlex

Proc Amer Assoc Cancer Res, Volume 45, 2004 4599 This study aims to model hyperacute rejection (HAR) in a small animal as a potential therapeutic approach to cancer. Hyperacute rejection is a rapid immunological response mediated by the binding of natural antibodies and the consequent activation of the complement cascade leading to cell lysis. Solid organ xenotransplantation from pig to old World primate results in HAR due to recognition of the galactose(α1,3)galactose (αGal) epitope present on porcine endothelial cells by primate anti-αGal natural antibodies. The αGal epitope is synthesised by the enzyme (α1,3)galactosyl transferase ((α1,3)GT) that is absent in humans. The eventual therapeutic goal in humans of HAR mimicry would be to deliver the (α1,3)GT gene to tumour endothelial cells leading to vascular destruction. An (α1,3)GT ko mouse has been generated that, analogous with humans, does not express αGal on the cell surface and produces anti-αGal IgM. Serum titres of anti-αGal IgM can be increased by intraperitoneal immunisation with hypotonically lysed rabbit red blood cells. Murine complement is less potent than human complement and serum from immunised (α1,3)GT ko mice must be augmented with exogenous rabbit complement in order that in vitro cytotoxicity against αGal positive murine endothelial target cells is equivalent to that of human serum. The (α1,3)GT ko mouse has been crossed with a nude mouse to create a double knockout to allow the growth of xenografted human tumours. Subcutaneous co-injection of irradiated (α1,3)GT retrovirus producer cells with human tumour cells causes in vivo transduction with (α1,3)GT and consequent αGal cell surface expression. Pseudotyping of the retroviral envelope results in selective transduction of either the stromal or tumour cell compartment. In experiments in progress the intravenous administration of serum from immunised (α1,3)GT ko mice and rabbit complement is expected to cause lysis by HAR of αGal positive murine stromal cells in tumour bearing nude/ko animals. This is analogous with the hyperacute rejection of αGal positive hearts seen in immunised (α1,3)GT ko mice after the administration of rabbit complement in transplantation experiments. The effect of the destruction of a small number of stromal and vascular cells is expected to be amplified and cause the destruction of a larger number of tumour cells. This should be manifest as a reduction in the rate of tumour growth and in the histological disappearance of αGal positive areas in treated animals in comparison with untreated controls. The validity of hyperacute rejection mimicry as a therapeutic strategy for cancer is based on the assumption that individuals with cancer have adequate levels and function of anti-αGal antibodies and serum complement proteins. This is currently under investigation experimentally in a group of 50 individuals and data will be presented to address this question.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.008
Threshold uncertainty score0.026

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.000
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0080.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.161
GPT teacher head0.483
Teacher spread0.322 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2004
Admission routes1
Has abstractyes

Explore more

Same venueCancer ResearchSame topicXenotransplantation and immune responseFrench-language works237,207